MoonLake Immunotherapeutics
MLTX
#3736
Rank
HK$21.21 B
Marketcap
HK$336.36
Share price
-0.89%
Change (1 day)
-28.35%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -HK$0.85 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -HK$0.43 Billion, an increase over its 2022 earnings that were of -HK$0.51 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -HK$0.85 Billion100.9%
2023 -HK$0.43 Billion-16.81%
2022 -HK$0.51 Billion